Roche Holding AG’s experimental breast-cancer pill failed to meet the main goal of a study, a blow to the drugmaker’s efforts to develop a next-generation hormone therapy that caused the shares to ...

TAMPA, Fla. - TuHURA Biosciences, Inc. (NASDAQ:HURA) has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration for its VISTA inhibiting antibody, TBS-2025, to ...

Share on Pinterest A new study explores the effects of diet and exercise in preventing weight gain. Design by MNT; Photography by Nadine Greeff/Stocksy & BONNINSTUDIO/Stocksy Over the last few years, ...

A new study led by researchers at National Jewish Health has revealed that, while a wide range of viruses can cause lower respiratory tract illnesses (LRIs) in infants, certain viruses and viral ...

There are quite a few locked safes that you'll encounter throughout Mafia: The Old Country. Some of these are required to progress the main story, while others are ...

This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component. The abstract by Wang et al, entitled “Phase Ib/II study of fluzoparib in ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. In what researchers hope could be a case of 1 + ...

Some additives in ultraprocessed foods are known to be harmful to the body – but what about when these ingredients are combined? A new study, published in the journal PLOS Medicine, revealed that the ...

A combination of two widely available drugs could significantly reduce deaths from heart attacks, a study has found. New evidence shows combining statins with ezetimibe immediately is more effective ...

A new study shows that dogs trained to use soundboards to 'talk' are capable of making two-word button combinations that go beyond random behavior or simple imitation of their owners. A new study from ...

SAN DIEGO--(BUSINESS WIRE)--Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced interim data from its lead clinical ...